AURKA and breast carcinoma: For example, Fadaka et al. [46] use molecular docking to suggest that AURKA might be regulated by miR-32-3p in breast cancer, and analyse binding energy and specific miRNA–mRNA interactions, although they did not directly probe the targeting.